OAC

OMERS Administration Corp Portfolio holdings

AUM $15.6B
1-Year Est. Return 26.14%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+26.14%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$15.6B
AUM Growth
+$1.52B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
1,205
New
Increased
Reduced
Closed

Top Buys

1
+$993M
2
+$414M
3
+$242M
4
MRK icon
Merck
MRK
+$153M
5
GILD icon
Gilead Sciences
GILD
+$152M

Top Sells

1
+$424M
2
+$184M
3
+$153M
4
NKE icon
Nike
NKE
+$150M
5
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$145M

Sector Composition

1 Technology 22.77%
2 Financials 16.4%
3 Industrials 10.28%
4 Healthcare 9.9%
5 Communication Services 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SND icon
926
Smart Sand
SND
$245M
$191K ﹤0.01%
37,300
+800
AVTR icon
927
Avantor
AVTR
$6.5B
$190K ﹤0.01%
24,181
IRD
928
Opus Genetics
IRD
$378M
$189K ﹤0.01%
41,600
-46,300
CHYM
929
Chime Financial
CHYM
$6.92B
$189K ﹤0.01%
+10,100
IMUX icon
930
Immunic
IMUX
$197M
$187K ﹤0.01%
+16,830
IMMX icon
931
Immix Biopharma
IMMX
$599M
$186K ﹤0.01%
20,400
-54,300
CTNM
932
Contineum Therapeutics
CTNM
$461M
$185K ﹤0.01%
14,200
-20,700
NEXN
933
Nexxen International
NEXN
$477M
$185K ﹤0.01%
28,347
ATHM icon
934
Autohome
ATHM
$2.02B
$184K ﹤0.01%
+10,577
LTRX icon
935
Lantronix
LTRX
$332M
$183K ﹤0.01%
35,000
-9,900
APADR
936
DELISTED
A Paradise Acquisition Corp Rights
APADR
$181K ﹤0.01%
400,000
ZURA icon
937
Zura Bio
ZURA
$348M
$177K ﹤0.01%
29,800
-37,400
AVTX icon
938
Avalo Therapeutics
AVTX
$715M
$176K ﹤0.01%
11,800
-7,800
MNTN
939
MNTN Inc
MNTN
$716M
$176K ﹤0.01%
20,000
-18,800
OCGN icon
940
Ocugen
OCGN
$464M
$175K ﹤0.01%
96,500
-234,800
OPEN icon
941
Opendoor
OPEN
$4.78B
$175K ﹤0.01%
37,300
+12,000
CODA icon
942
Coda Octopus Group
CODA
$142M
$173K ﹤0.01%
+15,300
FWDI
943
Forward Industries Inc
FWDI
$296M
$172K ﹤0.01%
38,900
+12,100
LCTX icon
944
Lineage Cell Therapeutics
LCTX
$302M
$172K ﹤0.01%
109,000
-174,200
DUOT icon
945
Duos Technologies
DUOT
$408M
$170K ﹤0.01%
24,800
-17,600
FACTU
946
FACT II Acquisition Corp Unit
FACTU
$168K ﹤0.01%
15,730
+365
CHPT icon
947
ChargePoint
CHPT
$215M
$167K ﹤0.01%
34,400
-28,800
LXRX icon
948
Lexicon Pharmaceuticals
LXRX
$844M
$167K ﹤0.01%
106,800
-167,000
PURR
949
Hyperliquid Strategies Inc
PURR
$1.37B
$166K ﹤0.01%
32,700
-11,000
DHX icon
950
DHI Group
DHX
$159M
$166K ﹤0.01%
+59,000
36 37
38
39 40